Eudoxia-Evaggelia Koravou

Real-world data of thrombotic microangiopathy management: The key role of ADAMTS13 activity and complement testing

M. Papathanasiou, G. Karavalakis, A. Anagnostopoulos, 2021 .

Predictors of Transplant-Associated Thrombotic Microangiopathy in Patients With Overlap or Chronic Graft-vs-Host-Disease.

T. Chatzikonstantinou, E. Yannaki, A. Anagnostopoulos, 2021, Transplantation proceedings.

Endothelial and Complement Activation As Predictors of Survival in Adult Allogeneic Hematopoietic Cell Transplantation

T. Chatzikonstantinou, E. Yannaki, A. Anagnostopoulos, 2020, HemaSphere.

Pre- and Post-transfusion Complement Activation in Transfusion-dependent β-thalassaemia

A. Anagnostopoulos, E. Gavriilaki, A. Papalexandri, 2018, HemaSphere.

In vitro evidence of complement activation in patients with sickle cell disease

M. Mainou, A. Anagnostopoulos, A. Athanasiadou, 2017, Haematologica.

Caplacizumab for immune thrombotic thrombocytopenic purpura: real-world multicenter data

A. Symeonidis, I. Sakellari, E. Gavriilaki, 2023, Frontiers in Medicine.